Progressive obesity alters ovarian folliculogenesis with impacts on pro-inflammatory and steroidogenic signaling in female mice

Biology of Reproduction

Volumn 91, Issue 4, 2014, Pages

  Nteeba, Jackson ^a   Ganesan, Shanthi ^a   Keating, Aileen F ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Obesity; Ovary; Steroidogenesis

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; AROMATASE; CD3 ANTIGEN; CD4 ANTIGEN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERMEDIN; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; RANTES; STEROIDOGENIC ACUTE REGULATORY PROTEIN; CYTOKINE; GLUCOSE BLOOD LEVEL; STEROID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIESTRUS; ESTRUS; FEMALE; GENE EXPRESSION; IMMUNOCOMPETENT CELL; METESTRUS; MOUSE; NONHUMAN; OBESITY; OVARY CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROESTRUS; PROTEIN EXPRESSION; PUBERTY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; WESTERN BLOTTING; ANIMAL; BODY WEIGHT; ESTRUS CYCLE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OVARY FOLLICLE; PHYSIOLOGY;

AGOUTI; MUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CYTOKINES; ESTROUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; MICE; NF-KAPPA B; OBESITY; OVARIAN FOLLICLE; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROIDS;

EID: 84911406795     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.121343     Document Type: Article

References (91)

1. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009; 30:624-712.
2. Voutilainen R, Tapanainen J, Chung BC, Matteson KJ, Miller WL. Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17 alpha-hydroxylase/17, 20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 1986; 63:202-207.
3. Jamnongjit M, Hammes SR. Ovarian steroids: the good, the bad, and the signals that raise them. Cell Cycle 2006; 5:1178-1183.
4. Piquette GN, LaPolt PS, Oikawa M, Hsueh AJ. Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinol 1991; 128:2449-2456.
5. Mason JI, Rainey WE. Steroidogenesis in the human fetal adrenal: a role for cholesterol synthesized de novo. J Clin Endocrinol Metab 1987; 64: 140-147.
6. Miller WL. StAR search-what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol 2007; 21:589-601.
7. Hall PF. Cytochromes P-450 and the regulation of steroid synthesis. Steroids 1986; 48:131-196.
8. Simpson ER. Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis. Mol Cell Endocrinol 1979; 13:213-227.
9. Agarwal AK, Auchus RJ. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinol 2005; 146:2531-2538.
10. Lee TC, Miller WL, Auchus RJ. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J Clin Endocrinol Metab 1999; 84:2104-2110.
11. Rachón D, Teede H. Ovarian function and obesity-interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 2010; 316:172-179.
12. Ogbuji QC. Obesity and reproductive performance in women. Afr J Reprod Health 2010; 14:143-151.
13. Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction 2010; 140:347-364.
14. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379:2162-2172.
15. Gilboa SM, Correa A, Botto LD, Rasmussen SA, Waller DK, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Study NBDP. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2010. 202:51.e51-51.e10.
16. Rasmussen KM, Kjolhede CL. Maternal obesity: a problem for both mother and child. Obesity 2008; 16:929-931.
17. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9:359-372.
18. Nestler JE. Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 2000; 24(suppl 2):S71-73.
19. Pasquali R, Gambineri A, Pagotto U. Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome. Br J Obstet Gynecol 2006; 113:1148-1159.
20. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction 2009; 138: 903-919.
21. Amsterdam A, Keren-Tal I, Aharoni D, Dantes A, Land-Bracha A, Rimon E, Sasson R, Hirsh L. Steroidogenesis and apoptosis in the mammalian ovary. Steroids 2003; 68:861-867.
22. Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL. Macrophage contributions to ovarian function. Hum Reprod Update 2004; 10:119-133.
23. Bornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis. Mol Cell Endocrinol 2004; 215:135-141.
24. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011; 17:17-33.
25. Loret de Mola JR, Flores JP, Baumgardner GP, Goldfarb JM, Gindlesperger V, Friedlander MA. Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin-6 signal. Obstet Gynecol 1996; 87:581-587.
26. Loret de Mola JR, Baumgardner GP, Goldfarb JM, Friedlander MA. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. Hum Reprod 1996; 11: 1377-1380.
27. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007; 67:585-592.
28. Lane D, Matte I, Rancourt C, Piché A. Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer 2011; 11:210.
29. Chou CH, Wei LH, Kuo ML, Huang YJ, Lai KP, Chen CA, Hsieh CY. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3KAkt/ NF-kappaB pathway by lysophosphatidic acid, an ovarian canceractivating factor. Carcinogenesis 2005; 26:45-52.
30. Carlberg M, Nejaty J, Fröysa B, Guan Y, Söder O, Bergqvist A. Elevated expression of tumour necrosis factor alpha in cultured granulosa cells from women with endometriosis. Hum Reprod 2000; 15:1250-1255.
31. Michaud EJ, Bultman SJ, Klebig ML, van Vugt MJ, Stubbs LJ, Russell LB, Woychik RP. A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc Natl Acad Sci U S A 1994; 91:2562-2566.
32. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A 1995; 92:4728-4732.
33. Carroll L, Voisey J, van Daal A. Mouse models of obesity. Clin Dermatol 2004; 22:345-349.
34. Lu D, Willard D, Patel I, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik R, Wilkison W. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 1994; 371:799-802.
35. Byers SL, Wiles MV, Dunn SL, Taft RA. Mouse estrous cycle identification tool and images. PLoS One 2012; 7:e35538.
36. Nteeba J, Ortinau LC, Perfield JW, Keating AF. Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues. Mol Reprod Develop 2013; 80:948-958.
37. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health (Lond Engl) 2008; 4:183-194.
38. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13: 1502-1505.
39. Depalo R, Garruti G, Totaro I, Panzarino M, Vacca MP, Giorgino F, Selvaggi LE. Oocyte morphological abnormalities in overweight women undergoing in vitro fertilization cycles. Gynecol Endocrinol 2011; 27: 880-884.
40. Jungheim ES, Schoeller EL, Marquard KL, Louden ED, Schaffer JE, Moley KH. Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring. Endocrinol 2010; 151:4039-4046.
41. Castillo-Martinez L, Lopez-Alvarenga JC, Villa AR, Gonzalez-Barranco J. Menstrual cycle length disorders in 18- to 40-y-old obese women. Nutrition 2003; 19:317-320.
42. Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 1979; 3:57-73.
43. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705-2712.
44. Bellver J, Pellicer A, Garcia-Velasco JA, Ballesteros A, Remohi J, Meseguer M. Obesity reduces uterine receptivity: clinical experience from 9, 587 first cycles of ovum donation with normal weight donors. Fertil Steril 2013; 100:1050-1058.
45. Jungheim ES, Schon SB, Schulte MB, DeUgarte DA, Fowler SA, Tuuli MG. IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis. Hum Reprod 2013; 28:2720-2727.
46. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
47. Ferrante AW. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007; 262:408-414.
48. Yang Z, Norwood KA, Smith JE, Kerl JG, Wood JR. Genes involved in the immediate early response and epithelial-mesenchymal transition are regulated by adipocytokines in the female reproductive tract. Mol Reprod Dev 2012; 79:128-137.
49. Balasubramanian P, Jagannathan L, Mahaley RE, Subramanian M, Gilbreath ET, Mohankumar PS, Mohankumar SM. High fat diet affects reproductive functions in female diet-induced obese and dietary resistant rats. J Neuroendocrinol 2012; 24:748-755.
50. Akamine EH, Marcal AC, Camporez JP, Hoshida MS, Caperuto LC, Bevilacqua E, Carvalho CR. Obesity induced by high-fat diet promotes insulin resistance in the ovary. J Endocrinol 2010; 206:65-74.
51. McCann JP, Reimers TJ. Effects of obesity on insulin and glucose metabolism in cyclic heifers. J Anim Sci 1986; 62:772-782.
52. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718-726.
53. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008; 15:857-861.
54. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88:1516-1522.
55. Nteeba J, Ganesan S, Keating AF. Impact of obesity on ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene in mice. Biol Reprod 2014; 90:68.
56. Wang N, Luo LL, Xu JJ, Xu MY, Zhang XM, Zhou XL, Liu WJ, Fu YC. Obesity accelerates ovarian follicle development and follicle loss in rats. Metabolism 2014; 63:94-103.
57. Robker RL, Akison LK, Bennett BD, Thrupp PN, Chura LR, Russell DL, Lane M, Norman RJ. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderateweight women. J Clin Endocrinol Metab 2009; 94:1533-1540.
58. Kezele PR, Nilsson EE, Skinner MK. Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002; 192:37-43.
59. Kezele P, Skinner MK. Regulation of ovarian primordial follicle assembly and development by estrogen and progesterone: endocrine model of follicle assembly. Endocrinol 2003; 144:3329-3337.
60. Britt KL, Drummond AE, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK. The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol 2001; 79:181-185.
61. Britt KL, Saunders PK, McPherson SJ, Misso ML, Simpson ER, Findlay JK. Estrogen actions on follicle formation and early follicle development. Biol Reprod 2004; 71:1712-1723.
62. Chen Y, Jefferson WN, Newbold RR, Padilla-Banks E, Pepling ME. Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo. Endocrinol 2007; 148:3580-3590.
63. Liu K. Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci 2006; 11:126-135.
64. Nteeba J, Ross JW, Perfield Ii JW, Keating AF. High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression. Reprod Toxicol 2013; 42:68-77.
65. Ahn SW, Gang G-T, Kim YD, Ahn R-S, Harris RA, Lee C-H, Choi H-S. Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells. J Biol Chem 2013; 288: 15937-15946.
66. Otani T, Maruo T, Yukimura N, Mochizuki M. Effect of insulin on porcine granulosa cells: implications of a possible receptor mediated action. Acta Endocrinol (Copenh) 1985; 108:104-110.
67. Spicer LJ, Echternkamp SE. The ovarian insulin and insulin-like growth factor system with an emphasis on domestic animals. Domest Anim Endocrinol 1995; 12:223-245.
68. Ellison PT. Energetics and reproductive effort. Am J Hum Biol 2003; 15: 342-351.
69. Clancy KB, Klein LD, Ziomkiewicz A, Nenko I, Jasienska G, Bribiescas RG. Relationships between biomarkers of inflammation, ovarian steroids, and age at menarche in a rural Polish sample. Am J Hum Biol 2013; 25: 389-398.
70. La Vignera S, Condorelli R, Bellanca S, La Rosa B, Mousaví A, Busà B, Vicari LO, Vicari E. Obesity is associated with a higher level of proinflammatory cytokines in follicular fluid of women undergoing medically assisted procreation (PMA) programs. Eur Rev Med Pharmacol Sci 2011; 15:267-273.
71. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95:2409-2415.
72. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95:2111-2119.
73. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 1996; 97:1111-1116.
74. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
75. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinol 1994; 134:264-270.
76. Mikuni M. [Effect of interleukin-2 and interleukin-6 on ovary in the ovulatory period-establishment of the new ovarian perfusion system and influence of interleukins on ovulation rate and steroid secretion]. Hokkaido Igaku Zasshi 1995; 70:561-572.
77. Van der Hoek KH, Woodhouse CM, Brännström M, Norman RJ. Effects of interleukin (IL)-6 on luteinizing hormone- and IL-1beta-induced ovulation and steroidogenesis in the rat ovary. Biol Reprod 1998; 58: 1266-1271.
78. Roby KF, Weed J, Lyles R, Terranova PF. Immunological evidence for a human ovarian tumor necrosis factor-alpha. J Clin Endocrinol Metab 1990; 71:1096-1102.
79. Andreani CL, Payne DW, Packman JN, Resnick CE, Hurwitz A, Adashi EY. Cytokine-mediated regulation of ovarian function. Tumor necrosis factor alpha inhibits gonadotropin-supported ovarian androgen biosynthesis. J Biol Chem 1991; 266:6761-6766.
80. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 2006; 12:5055-5063.
81. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005; 3:28.
82. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW. Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 2000; 17: 222-228.
83. Hefler LA, Gregg AR. Inducible and endothelial nitric oxide synthase: genetic background affects ovulation in mice. Fertil Steril 2002; 77: 147-151.
84. Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB. Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol 2002; 86:134-137.
85. Szczepańska M, Koźlik J, Skrzypczak J, Mikolajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003; 79: 1288-1293.
86. Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility-a clinician's perspective. Reprod Biomed Online 2005; 11:641-650.
87. Bonizzi G, Karin M. The two NF-jB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25:280-288.
88. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195-2224.
89. Mercurio F, Manning AM. NF-kappaB as a primary regulator of the stress response. Oncogene 1999; 18:6163-6171.
90. Ma CH, Yan LY, Qiao J, Sha W, Li L, Chen Y, Sun QY. Effects of tumor necrosis factor-alpha on porcine oocyte meiosis progression, spindle organization, and chromosome alignment. Fertil Steril 2010; 93:920-926.
91. DiDonato J, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012; 246:379-400.